Search Results - "Hogue, Susan L."

Refine Results
  1. 1

    EPIPEN4SCHOOLS® Survey Combined Analysis: Staff Training and Use of Epinephrine Auto-Injectors by Hogue, Susan L., PharmD, MPH, Silvia, Suyapa, PhD, Hollis, Kelly, MBA, Wooddell, Margaret J., PhD, MBA, Goss, Diana, BS, Odom, Dawn, MS, Cooney, Darryl, MS, White, Martha V., MD, CPI

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…Conclusions Thirty-eight percent of anaphylactic events were treated with EAIs provided by the EpiPen4Schools program, highlighting the importance of stocking…”
    Get full text
    Journal Article
  2. 2

    EPIPEN4SCHOOLS® Survey Combined Analysis: Prevalence and Triggers of Anaphylactic Events by White, Martha V., MD, CPI, Silvia, Suyapa, PhD, Hollis, Kelly, MBA, Wooddell, Margaret J., PhD, MBA, Goss, Diana, BS, Odom, Dawn, MS, Bartsch, Jennifer, MStat, Hogue, Susan L., PharmD, MPH

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…Of the events occurring in students with data on grade level (n=891), 44.9% (400/891) occurred in students in high school, 18.9% (168/891) occurred in students…”
    Get full text
    Journal Article
  3. 3

    Barriers to the Administration of Epinephrine in Schools by Hogue, Susan L., Muniz, Rafael, Herrem, Christopher, Silvia, Suyapa, White, Martha V.

    Published in The Journal of school health (01-05-2018)
    “…ABSTRACT BACKGROUND Anaphylaxis is a serious and growing concern in the school setting as the prevalence of food allergies and food‐induced severe allergic…”
    Get full text
    Journal Article
  4. 4

    Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples by Brogan, Andrew P, DeMuro, Carla, Barrett, Amy M, D'Alessio, Denise, Bal, Vasudha, Hogue, Susan L

    “…Health authorities and payers increasingly recognize the importance of patient perspectives and patient-reported outcomes (PROs) in health care decision…”
    Get full text
    Journal Article
  5. 5

    Review of the cost of venous thromboembolism by Fernandez, Maria M, Hogue, Susan, Preblick, Ronald, Kwong, Winghan Jacqueline

    Published in ClinicoEconomics and outcomes research (01-01-2015)
    “…Venous thromboembolism (VTE) is the second most common medical complication and a cause of excess length of hospital stay. Its incidence and economic burden…”
    Get full text
    Journal Article
  6. 6

    Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States by Brogan, Andrew P, Hogue, Susan L, Vekaria, Renu M, Reynolds, Ian, Coukell, Allan

    “…In recent years, value assessment frameworks have been introduced to inform discussions about how to define and assess value in the U.S. health care system…”
    Get full text
    Journal Article
  7. 7

    Prevalence and triggers of anaphylactic events in schools by White, Martha V, Silvia, Suyapa, Muniz, Rafael, Herrem, Christopher, Hogue, Susan L

    Published in Allergy and asthma proceedings (01-07-2017)
    “…Prevention and management of anaphylaxis in schools is an area of active interest as allergy and asthma rates in children continue to increase. A greater…”
    Get more information
    Journal Article
  8. 8

    EpiPen4Schools pilot survey: Occurrence of anaphylaxis, triggers, and epinephrine administration in a U.S. school setting by White, Martha V, Hogue, Susan L, Bennett, M Elizabeth, Goss, Diana, Millar, Kimrey, Hollis, Kelly, Siegel, Peter H, Wolf, Ray A, Wooddell, Margaret J, Silvia, Suyapa

    Published in Allergy and asthma proceedings (01-07-2015)
    “…Although epinephrine is the treatment of choice for anaphylaxis, it remains underused. This study was designed to describe anaphylactic events and epinephrine…”
    Get more information
    Journal Article
  9. 9

    Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 european countries : A cross-sectional patient survey by WILLIAMS, Valerie S. L, BALDWIN, David S, HOGUE, Susan L, FEHNEL, Sheri E, HOLLIS, Kelly A, EDIN, Heather M

    Published in The journal of clinical psychiatry (01-02-2006)
    “…Sexual dysfunction is a common side effect of antidepressant treatment, but recognition of the problem is variable. The aim of this study was to estimate the…”
    Get full text
    Journal Article
  10. 10

    Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools(®) pilot survey by Hogue, Susan L, Goss, Diana, Hollis, Kelly, Silvia, Suyapa, White, Martha V

    Published in Journal of asthma and allergy (01-01-2016)
    “…Anaphylaxis is a serious, potentially life-threatening condition. Adequate preparation for anaphylaxis management is imperative for school personnel. This…”
    Get full text
    Journal Article
  11. 11

    Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery by Naslund, Michael, Eaddy, Michael T., Hogue, Susan L., Kruep, Eric J., Shah, Manan B.

    Published in Current medical research and opinion (01-11-2009)
    “…Abstract Objective: Pharmacologic treatment of lower urinary tract symptoms from benign prostatic hyperplasia (BPH) commonly includes α-blockers (ABs) and…”
    Get full text
    Journal Article
  12. 12

    Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence by Pettaway, Curtis A., Lamerato, Lois E., Eaddy, Michael T., Edwards, Jessie K., Hogue, Susan L., Crane, Martin M.

    Published in BJU international (01-10-2011)
    “…Study Type – Prevalence (prospective cohort with good follow‐up) Level of Evidence 1b What’s known on the subject? and What does the study add? Previous…”
    Get full text
    Journal Article
  13. 13

    Impact of comorbid attention deficit disorder on the direct medical costs of treating adults with depression in managed care by FISHMAN, Paul A, STANG, Paul E, HOGUE, Susan L

    Published in The journal of clinical psychiatry (01-02-2007)
    “…To assess the impact of comorbid attention deficit disorder (ADD) on the direct medical costs of treating adults with depression in a mixed-model health…”
    Get full text
    Journal Article
  14. 14

    Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression by McLaughlin, Trent, Hogue, Susan L, Stang, Paul E

    Published in American journal of therapeutics (01-03-2007)
    “…The main aim of this study was to examine the impact of dosing regimens on patients' persistence to bupropion. A nationally representative patient-level…”
    Get full text
    Journal Article
  15. 15

    5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives by Naslund, Michael, Regan, Timothy S, Ong, Christine, Hogue, Susan L

    Published in The American journal of managed care (01-05-2008)
    “…This article presents background information and highlights key findings from a managed care perspective related to enlarged prostate (EP) in Medicare-eligible…”
    Get full text
    Journal Article
  16. 16

    Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population by Stang, Paul, Suppapanaya, Nittaya, Hogue, Susan L, Park, Daniel, Rigney, Una

    Published in American journal of therapeutics (01-05-2007)
    “…In this study, the impact of dosing frequency [once daily with bupropion extended-release (XL) versus twice daily with bupropion sustained-release (SR)] on…”
    Get full text
    Journal Article
  17. 17

    An assessment of patient preference and adherence to treatment with Wellbutrin SR: A web-based survey by Granger, Arthur L., Fehnel, Sheri E., Hogue, Susan L., Bennett, Lee, Edin, Heather M.

    Published in Journal of affective disorders (01-02-2006)
    “…Research has shown that lack of treatment adherence is a serious problem, especially among patients with psychiatric disorders. The current study was conducted…”
    Get full text
    Journal Article
  18. 18

    Clinical and economic impact of early versus delayed 5-alpha reductase inhibitor therapy in men taking alpha blockers for symptomatic benign prostatic hyperplasia by Kruep, Eric J, Hogue, Susan L, Eaddy, Michael T, Chandra, Monica D

    Published in P&T (Lawrenceville, N.J.) (01-08-2011)
    “…Recent clinical trials indicate that combining an alpha blocker for rapid symptom improvement and a 5-alpha reductase inhibitor (5-ARI) to reduce the risk of…”
    Get full text
    Journal Article
  19. 19

    Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men by Naslund, Michael, Eaddy, Michael T, Kruep, Eric J, Hogue, Susan L

    Published in The American journal of managed care (01-05-2008)
    “…To assess cost differences between dutasteride and finasteride use within the first year of initiating treatment for enlarged prostate (EP) among men aged > or…”
    Get full text
    Journal Article
  20. 20

    The economic impact of delaying 5-alpha reductase inhibitor therapy in men receiving treatment for symptomatic benign prostatic hyperplasia by Naslund, Michael, Eaddy, Michael T, Hogue, Susan L, Kruep, Eric J, Shah, Manan B

    Published in American health & drug benefits (01-05-2011)
    “…Pharmacologic treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia often includes alpha-blockers and 5-alpha reductase…”
    Get full text
    Journal Article